Abstract |
Biological models are necessary tools for gaining insight into underlying mechanisms governing complex pathologies such as cancer in the bone. Models range from in vitro tissue culture systems to in vivo models and can be used with corresponding epidemiological and clinical data to understand disease etiology, progression, driver mutations, and signaling pathways. In bone cancer, as with many other cancers, in vivo models are often too complex to study specific cell-cell interactions or protein roles, and 2D models are often too simple to accurately represent disease processes. Consequently, researchers have increasingly turned to 3D in vitro tissue engineered models as a useful compromise. In this review, tissue engineered 3D models of bone and cancer are described in depth and compared to 2D models. Biomaterials and cell types used are described, and future directions in the field of tissue engineered bone cancer models are proposed.
|
Authors | Anna M Sitarski, Heather Fairfield, Carolyne Falank, Michaela R Reagan |
Journal | ACS biomaterials science & engineering
(ACS Biomater Sci Eng)
Vol. 4
Issue 2
Pg. 324-336
(Feb 12 2018)
ISSN: 2373-9878 [Print] United States |
PMID | 29756030
(Publication Type: Journal Article)
|